Login / Signup

Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary Interventions.

Monica VerdoiaMatteo NardinRocco GiosciaAndrea RognoniGiuseppe De Luca
Published in: Current vascular pharmacology (2024)
Among elderly patients receiving DAPT after PCI, HRPR is common with low-dose prasugrel. A greater BMI, especially for values ≥26, is the only independent predictor of HRPR with prasugrel 5 mg.
Keyphrases